The new antipsychotic compounds: is a clinical choice algorithm possible?
作者信息
Wirshing W C
出版信息
West J Med. 1998 Jul;169(1):43-4.
Abstract
摘要
相似文献
1
The new antipsychotic compounds: is a clinical choice algorithm possible?新型抗精神病药物：是否有可能建立一种临床选择算法？
West J Med. 1998 Jul;169(1):43-4.
2
Two new atypical antipsychotics: advantages and disadvantages.两种新型非典型抗精神病药物：优缺点
S D J Med. 1998 Aug;51(8):285-6.
3
The value of atypical antipsychotics in the treatment of schizophrenia.非典型抗精神病药物在精神分裂症治疗中的价值。
Manag Care. 2002 Jul;11(7 Suppl):8-12; discussion 12-3.
4
Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.接受氯氮平、利培酮、奥氮平或喹硫平治疗的患者体重及代谢参数的六个月回顾
J Clin Psychiatry. 2003 Sep;64(9):1133-4. doi: 10.4088/jcp.v64n0921f.
5
Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.在奥氮平和喹硫平治疗期间血清肌酸激酶大幅升高，而在氯氮平治疗期间未出现这种情况。
Psychopharmacology (Berl). 2000 Jun;150(3):347-8. doi: 10.1007/s002130000464.
6
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.使用非典型抗精神病药物治疗的患者的血清瘦素和甘油三酯水平
J Clin Psychiatry. 2003 May;64(5):598-604. doi: 10.4088/jcp.v64n0516.
7
Schizophrenia, VI: Treatments.精神分裂症，第六章：治疗方法。
Am J Psychiatry. 2003 Oct;160(10):1748. doi: 10.1176/appi.ajp.160.10.1748.
8
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.糖尿病与使用非典型抗精神病药物治疗精神分裂症之间的关联。
Am J Psychiatry. 2002 Apr;159(4):561-6. doi: 10.1176/appi.ajp.159.4.561.
9
10
Conventional vs. newer antipsychotics in elderly patients.老年患者中传统抗精神病药物与新型抗精神病药物的比较
Am J Geriatr Psychiatry. 1999 Winter;7(1):70-6.
引用本文的文献
1
Conventional and atypical antipsychotics in the elderly : a review.老年人的传统和非典型抗精神病药物：综述。
Clin Drug Investig. 2003;23(5):287-322. doi: 10.2165/00044011-200323050-00001.
2
Adverse effects of atypical antipsychotics in the elderly: a review.老年患者使用非典型抗精神病药物的不良反应：综述
Drugs Aging. 2006;23(12):937-56. doi: 10.2165/00002512-200623120-00002.
3
Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.增强的神经降压素神经传递参与抗精神病药物的临床相关行为效应：来自感觉运动门控动物模型的证据。
J Neurosci. 2001 Jan 15;21(2):601-8. doi: 10.1523/JNEUROSCI.21-02-00601.2001.
Zotero 插件